Stock Screener App
Free
-
Play Store
App Store
Install
Install
Dark
EN
Sign in
Watchlist
Top Lists
Markets
New
Options
Cryptos
Industries
Elite
Market Simulator
DMAC
$9.04
16.06%
-1.73
Diamedica Therapeutics Inc (DMAC)
Indicator
5
EX
1min
5min
Hourly
Daily
Weekly
Monthly
Line
Candle
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Similar to DMAC
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Diamedica Therapeutics Inc Stock (DMAC) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Period Length
3 Months
3 Months
3 Months
3 Months
3 Months
Research and Development
2.08%
8.15
7.99
6.70
6.44
5.82
Research and Development
2.08%
8.15
7.99
6.70
6.44
5.82
Operating Income/Loss
0.15%
-10.50
-10.48
-9.21
-9.03
-8.01
Income/Loss From Continuing Operations Before Tax
0.97%
-10.13
-10.04
-8.73
-8.61
-7.69
Income Tax Expense/Benefit
0.01
0.01
0.01
0.01
0.01
Net Income/Loss
0.97%
-10.14
-10.04
-8.74
-8.62
-7.70
Attributable To Parent
0.97%
-10.14
-10.04
-8.74
-8.62
-7.70
Basic Average Shares
0.19%
53.89
53.79
-
49.63
42.96
Basic Earnings Per Share
-0.19
-0.19
-
-0.17
-0.18
